Ax-S Pharma LLC was created to provide clear, constructive guidance about pre-market access to medicines in serious diseases.  Since 2013 the company has advised commercial, government, and non-profit clients on the regulation and best-practices of FDA-authorized Expanded Access, with an emphasis on scalability and data generation. In 2017, Ax-S Pharma launched the inaugural Expanded Access Summit ®, which has taken place annually in Cambridge MA and Washington DC and has become the largest in-person forum on pre-market access to medicines, worldwide. The 2020-2021 Ax-S Thursdays e-Conference Series on Expanding Access to New Medicines is a new 3- month installation of weekly LiveCasts, partnering, and on-demand video modules.  Its scope has widened to include a range of innovations that integrate clinical research into modern healthcare delivery. As the leading provider of education and advisory in its topic, Ax-S Pharma remains uninfluenced by third-party affiliations.  All programming is guided by its mission of making meaningfully-sized pre-market medicines access easier for stakeholders to undertake, for all patients in need, in all serious unsolved health conditions, in all parts of the world.